The treatment of pyogenic meningitis.
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000401:mortality; D008583:Meningitis, Haemophilus / Q000188:drug therapy*; D008585:Meningitis, Meningococcal / Q000188:drug therapy*; D008586:Meningitis, Pneumococcal / Q000188:drug therapy*; D008875:Middle Aged; D010400:Penicillin G / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D013411:Sulfadiazine; D002701:Chloramphenicol; D000667:Ampicillin; D010400:Penicillin G